TransUnion to restate financials, after discovering 'computational error' and 'material weakness' in financial reporting
TransUnion (TRU), one of the nation's major credit-score and credit-report providers, said on Monday that it would restate financials through nine months of last year after discovering an error related to a segment in the U.K. and a "material weakness" in its accounting protocols. The company, in a filing, said that financial statements in a quarterly report in October for the three- and nine-month periods ending Sept. 30, 2023 were "materially misstated and should no longer be relied upon." TransUnion said the mistake involved "an overstatement of approximately $80 million to the non-cash goodwill impairment that was reported within our consolidated statements of income and balance sheet," and stemmed from a "computational error" related to translating U.S. dollar values. The company said it would provide more information about the "material weakness" and steps to correct it in an amended filing. Shares fell 0.8% after hours.
-Bill Peters
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
01-08-24 1821ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom